Clinical Trial Update: Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI) and Fluorothymidine Positron Emission Tomography (FLT PET) in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy [NA]

View source ↗

Summary

This clinical trial evaluated Blood Oxygen Level Dependent (BOLD) MRI and Fluorothymidine PET (FLT PET) imaging in patients with locally advanced breast cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Ontario Clinical Oncology Group (OCOG) | Conditions: Locally Advanced Breast Cancer (LABC) | NA | Status: COMPLETED